Logo image of ENGN

ENGENE HOLDINGS INC (ENGN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ENGN - CA29286M1059 - Common Stock

9.31 USD
+0.09 (+0.98%)
Last: 1/16/2026, 8:09:48 PM
9.31 USD
0 (0%)
After Hours: 1/16/2026, 8:09:48 PM
Fundamental Rating

2

ENGN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 529 industry peers in the Biotechnology industry. While ENGN seems to be doing ok healthwise, there are quite some concerns on its profitability. ENGN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ENGN had negative earnings in the past year.
  • ENGN had a negative operating cash flow in the past year.
  • In the past 5 years ENGN reported 4 times negative net income.
  • ENGN had a negative operating cash flow in each of the past 5 years.
ENGN Yearly Net Income VS EBIT VS OCF VS FCFENGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M -80M -100M

1.2 Ratios

  • ENGN has a Return On Assets of -52.97%. This is comparable to the rest of the industry: ENGN outperforms 47.35% of its industry peers.
  • ENGN has a Return On Equity of -69.94%. This is comparable to the rest of the industry: ENGN outperforms 56.25% of its industry peers.
Industry RankSector Rank
ROA -52.97%
ROE -69.94%
ROIC N/A
ROA(3y)-23.55%
ROA(5y)-43.78%
ROE(3y)-30.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENGN Yearly ROA, ROE, ROICENGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 2K 4K 6K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ENGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ENGN Yearly Profit, Operating, Gross MarginsENGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025

5

2. Health

2.1 Basic Checks

  • ENGN has more shares outstanding than it did 1 year ago.
  • ENGN has a worse debt/assets ratio than last year.
ENGN Yearly Shares OutstandingENGN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ENGN Yearly Total Debt VS Total AssetsENGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 3.38 indicates that ENGN is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.38, ENGN is in the better half of the industry, outperforming 69.32% of the companies in the same industry.
  • A Debt/Equity ratio of 0.09 indicates that ENGN is not too dependend on debt financing.
  • ENGN's Debt to Equity ratio of 0.09 is on the low side compared to the rest of the industry. ENGN is outperformed by 61.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 3.38
ROIC/WACCN/A
WACCN/A
ENGN Yearly LT Debt VS Equity VS FCFENGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • ENGN has a Current Ratio of 6.30. This indicates that ENGN is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ENGN (6.30) is better than 64.58% of its industry peers.
  • ENGN has a Quick Ratio of 6.30. This indicates that ENGN is financially healthy and has no problem in meeting its short term obligations.
  • ENGN's Quick ratio of 6.30 is fine compared to the rest of the industry. ENGN outperforms 65.53% of its industry peers.
Industry RankSector Rank
Current Ratio 6.3
Quick Ratio 6.3
ENGN Yearly Current Assets VS Current LiabilitesENGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 50M 100M 150M 200M

1

3. Growth

3.1 Past

  • The earnings per share for ENGN have decreased strongly by -52.27% in the last year.
EPS 1Y (TTM)-52.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ENGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.29% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-5.99%
EPS Next 2Y8%
EPS Next 3Y16.72%
EPS Next 5Y20.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ENGN Yearly Revenue VS EstimatesENGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
ENGN Yearly EPS VS EstimatesENGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 2 -2

0

4. Valuation

4.1 Price/Earnings Ratio

  • ENGN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ENGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ENGN Price Earnings VS Forward Price EarningsENGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ENGN Per share dataENGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

  • ENGN's earnings are expected to grow with 16.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8%
EPS Next 3Y16.72%

0

5. Dividend

5.1 Amount

  • ENGN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ENGENE HOLDINGS INC

NASDAQ:ENGN (1/16/2026, 8:09:48 PM)

After market: 9.31 0 (0%)

9.31

+0.09 (+0.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)12-22
Earnings (Next)03-02
Inst Owners67.37%
Inst Owner Change0%
Ins Owners0.17%
Ins Owner Change0%
Market Cap601.24M
Revenue(TTM)N/A
Net Income(TTM)-117.30M
Analysts85.88
Price Target24.07 (158.54%)
Short Float %1.97%
Short Ratio0.77
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.73%
Min EPS beat(2)-25.95%
Max EPS beat(2)-11.52%
EPS beat(4)0
Avg EPS beat(4)-16.15%
Min EPS beat(4)-26.76%
Max EPS beat(4)-0.38%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.59%
EPS NQ rev (1m)11.07%
EPS NQ rev (3m)11.07%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.58
P/tB 3.59
EV/EBITDA N/A
EPS(TTM)-2.29
EYN/A
EPS(NY)-2.43
Fwd EYN/A
FCF(TTM)-1.56
FCFYN/A
OCF(TTM)-1.54
OCFYN/A
SpS0
BVpS2.6
TBVpS2.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -52.97%
ROE -69.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-23.55%
ROA(5y)-43.78%
ROE(3y)-30.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 291.75%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.3
Quick Ratio 6.3
Altman-Z 3.38
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)253.28%
Cap/Depr(5y)183.06%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.71%
EPS Next Y-5.99%
EPS Next 2Y8%
EPS Next 3Y16.72%
EPS Next 5Y20.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-97.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-27.94%
EBIT Next 3Y5.76%
EBIT Next 5Y23.79%
FCF growth 1Y-104.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.54%
OCF growth 3YN/A
OCF growth 5YN/A

ENGENE HOLDINGS INC / ENGN FAQ

What is the fundamental rating for ENGN stock?

ChartMill assigns a fundamental rating of 2 / 10 to ENGN.


What is the valuation status of ENGENE HOLDINGS INC (ENGN) stock?

ChartMill assigns a valuation rating of 0 / 10 to ENGENE HOLDINGS INC (ENGN). This can be considered as Overvalued.


How profitable is ENGENE HOLDINGS INC (ENGN) stock?

ENGENE HOLDINGS INC (ENGN) has a profitability rating of 1 / 10.


Can you provide the financial health for ENGN stock?

The financial health rating of ENGENE HOLDINGS INC (ENGN) is 5 / 10.


What is the expected EPS growth for ENGENE HOLDINGS INC (ENGN) stock?

The Earnings per Share (EPS) of ENGENE HOLDINGS INC (ENGN) is expected to decline by -5.99% in the next year.